FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| STAQ Pharma Inc | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-155 | 73177-155-27 | Ketamine Hydrochloride | Ketamine Hydrochloride | 5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-156 | 73177-156-35 | Ketamine Hydrochloride | Ketamine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-156 | 73177-156-02 | Ketamine Hydrochloride | Ketamine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | Ketamine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | Lidocaine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | Lidocaine Hydrochloride | 9 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | Lidocaine Hydrochloride | 20 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-121 | 73177-121-19 | Lidocaine Hydrochloride Epinephrine Bitartrate Tetracaine Hydrochloride | Lidocaine Hydrochloride Epinephrine Bitartrate Tetracaine Hydrochloride | .905 mg/1 mL; 5 mg/1 mL; 40 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-149 | 73177-149-43 | Methadone HCl | Methadone HCl | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-149 | 73177-149-02 | Methadone HCl | Methadone HCl | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-161 | 73177-161-43 | Methadone HCl | Methadone HCl | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-106 | 73177-106-05 | Midazolam | Midazolam | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-106 | 73177-106-25 | Midazolam | Midazolam | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-106 | 73177-106-04 | Midazolam | Midazolam | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-106 | 73177-106-28 | Midazolam | Midazolam | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-105 | 73177-105-30 | Morphine Sulfate | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-105 | 73177-105-28 | Morphine Sulfate | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-105 | 73177-105-25 | Morphine Sulfate | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-105 | 73177-105-02 | Morphine Sulfate | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-105 | 73177-105-05 | Morphine Sulfate | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-105 | 73177-105-16 | Morphine Sulfate | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-105 | 73177-105-01 | Morphine Sulfate | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-112 | 73177-112-03 | Phenylephrine | Phenylephrine | 40 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-108 | 73177-108-03 | Phenylephrine | Phenylephrine | 100 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-115 | 73177-115-03 | Phenylephrine | Phenylephrine | 80 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-115 | 73177-115-25 | Phenylephrine | Phenylephrine | 80 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-166 | 73177-166-25 | Phenylephrine | Phenylephrine | 160 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-127 | 73177-127-05 | Potassium Chloride | Potassium Chloride | 2 meq/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-159 | 73177-159-03 | Rocuronium Bromide | Rocuronium Bromide | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-159 | 73177-159-02 | Rocuronium Bromide | Rocuronium Bromide | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-14 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-20 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-26 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-13 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-169 | 73177-169-26 | Sodium Chloride | Sodium Chloride | 9 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-116 | 73177-116-02 | Succinylcholine Chloride | Succinylcholine Chloride | 20 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-116 | 73177-116-03 | Succinylcholine Chloride | Succinylcholine Chloride | 20 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STASKA PHARMACEUTICALS, INC. | 80098-030 | 80098-030-90 | ISOSULFAN BLUE | ISOSULFAN BLUE | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-001 | 73217-001-15 | Tacrolimus 0.02% Ophth | Tacrolimus | .2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-001 | 73217-001-10 | Tacrolimus 0.02% Ophth | Tacrolimus | .2 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-002 | 73217-002-15 | Tacrolimus 0.03% Ophth | Tacrolimus | .3 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-002 | 73217-002-10 | Tacrolimus 0.03% Ophth | Tacrolimus | .3 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-003 | 73217-003-10 | Tacrolimus 0.1% Ophth | Tacrolimus | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-004 | 73217-004-10 | Tacrolimus 0.5% Ophth | Tacrolimus | 5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-005 | 73217-005-10 | Tacrolimus 1% Ophth | Tacrolimus | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Tailstorm Health INC | 118651212 | 81483-0041 | 81483-0041-5 | Bevacizumab | 1.25 mg/.05 mL | 2025-1 | valid | 2026-10-31 | |
| Tailstorm Health INC | 118651212 | 81483-0046 | 81483-0046-4 | Semaglutide | .5 mg/.1 mL | 2025-1 | valid | 2026-10-31 |